Rena Conti and Peter Bach’s analysis of disproportionate share (DSH) hospitals in the 340B drug discount program -- published in the October issue of Health Affairs -- neglects an essential point: compared to non-340B DSH hospitals, 340B DSH hospitals
Read More...
Read the complete post at http://healthaffairs.org/blog/2014/10/08/drug-discount-analysis-misses-the-mark/
Posted
Oct 08 2014, 12:55 PM
by
Health Affairs Blog